News & Articles

Read the latest on how 39 trillion bacteria in the gut regulate our health

New software accurately generates and analyses data for clinical use and antibiotic research

Stanford researchers tease apart competing theories on how different species coexist.

Early warning sign of fish killing algal toxin that plagues fish farms could help protect our precious food supply

The ProtoCOL 3 HD provides accurate, traceable results for vaccine and antibiotic development

Discover the cutting-edge ways science and technology are taking on infectious diseases to help make the future healthier

How a researcher at UC San Diego is elucidating the role of microglial dysfunction in brain trauma and disorders

New Synapsys microbiology informatics solution will be demonstrated at the event

Researchers at University of Sheffield reveal the conversion of infrared light into electrical charges by photosynthetic proteins

Improved mass spec method nears industrial use, promoting a possible shift in global food allergen testing

To be in with a chance of winning a $500/£400/450€ Amazon voucher, just tell us which new product, instrument or consumable made the most difference to your lab in 2017

How research at the AMR Centre, UK, is accelerating the fight against antimicrobial resistance

Polymer surface grafting of anti-bacterial copper nanoparticles could reduce spread of infections and viruses

Bonnie Howell, Executive Director at Merck, discusses the use of ultrasensitive Quanterix technology to develop novel therapies for HIV and shares her hopes for a future world, free of the disease

Which new product, instrument or consumable has made the most difference to your lab? Nominate now for a chance to win a $500 Amazon voucher

The discovery of a new type of cellulose – the world’s most abundant biomolecule – offers opportunities for multiple advances from renewable fuel to antibiotics

Chemical signals that affect the human genome may help to fight infections and prevent cancer

Curetis and MGI's collaboration will enable short-term commercialisation of NGS-based molecular microbiology.